NCT00739609 2020-05-28
D-1MT
Lumos Pharma
Phase 1 Terminated
Clinical Trials
4 trialsNCT01792050 2020-05-28
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Lumos Pharma
Phase 2 Completed
NCT01042535 2018-04-11
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
NCT01302821 2017-02-23
C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Withdrawn